Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cognition Therapeutics Has Received A Notice Of Allowance For Its U.S. Patent Application 17/537,110 Titled "Compositions For Treating Neurodegenerative Diseases (Including Alzheimer's Disease And Cognitive Decline)"

Author: Benzinga Newsdesk | January 04, 2024 01:41pm

Posted In: CGTX